RhumbLine Advisers’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50,019
| Closed | -$69K | – | 4260 |
|
|
2025
Q1 | $69K | Buy |
50,019
+3,212
| +7% | +$4.43K | ﹤0.01% | 3491 |
|
|
2024
Q4 | $142K | Sell |
46,807
-396
| -0.8% | -$1.2K | ﹤0.01% | 3359 |
|
|
2024
Q3 | $235K | Buy |
47,203
+336
| +0.7% | +$1.67K | ﹤0.01% | 3154 |
|
|
2024
Q2 | $274K | Buy |
+46,867
| New | +$274K | ﹤0.01% | 3052 |
|